Clinical Trial Update: Fabhalta Capsules Specified Drug-use Survey

View source ↗

Summary

A recruiting clinical trial evaluating Fabhalta Capsules for C3 glomerulopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• C3 Glomerulopathy

Drugs mentioned

• Fabhalta Capsules

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: C3 Glomerulopathy | Status: RECRUITING